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NEUROLEPTIC MALIGNANT SYNDROME: A
CASE REPORT
C. N. CHIN
SUMMARY
The neuroleptic malignant syndrome is a rare
but potentially fatal complication of neuroleptic
administration. Many clinicians may not be
familiar with this complication. This case'report
highlights the clinical features of neuroleptic
malignant syndrome and its management.
CASE HISTORY
A 68-year-old married, Chinese, female was
brought to the Psychiatric Clinic by her relatives
in April 1985. There was a 12-month history of
deterioration of her personality and gross neglect
of personal hygiene. She would wander about
the streets and remove her clothes in public.
Her memory was poor and she would accuse
her children of persecuting her when she mis-
placed her personal belongings. There was no
loss of weight or appetite. She was unable to
sleep at night.
Prior to the onset of the illness, she was func-
tioning well, being able to look after herself and
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her grandchildren as well as keep house. Her
memory was good prior to the illness.
A thorough physical and neurological examina-
tion did not reveal any abnormalities, apart from
a fixed deformity of her right wrist due to mal-
union of an old fracture. She was afebrile.
On admission, the mental state examination
revealed a dishevelled unco-operative female. There
was no clouding of consciousness. She talked'
loudly, incessantly and incoherently. She was
extremely irritable and hostile, had delusions
of persecution. She was disorientated to time
and place. Her recent memory was impaired and
she had no insight to her illness.
A provisional diagnosis of dementia with
disturbed behaviour was made. The following
investigations were conducted: full blood picture,
VDR L, thyroid function test, urine examination,
renal profile were normal; chest and skull X-ray
reported as normal.
She was given Haloperidol 10 mgm I/M on
admission and subsequently Thioridazine 50 mgm
bd 100 mgm nocte. Two days after commence-
ment of Thioridazine, she developed marked
rigidity and pyrexia with elevated blood pressure,
incontinence and sweating. Examination for
sources of infection were negative and so were
investigations of CXR, ECG and urine examina-
tion. There was no neck stiffness.The medication was stopped and she was given
Procyclidine 10 mgm IfM. Good nursing care was
provided with four-hourly observations and tepid
sponging for her fever, which subsided in two days
(Fig. 1).
One week later, she was given Promazine 50
mgm BD. She developed pyrexia and rigidity
again within 48 hours. On stopping the neurolep-
tic, the fever subsided within two days.
DISCUSSION
When patients on neuroleptics develop fever,
infective causes are the most common reason
and this was carefully looked for in this patient.
However she also had severe rigidity, elevated
blood pressure and clouding of consciousness
with sweating. A diagnosis of the neuroleptic
malignant svndrorr.e (NMS) must be considered.
The description of this syndrome was first
reported by Delay and Deniker and the cardinal
symptoms are hyperpyrexia and rigidity. It is rare
with few reports but the potential danger is that
there is a mortality of 20% reported in one studv.'
This is especially so if the neuroleptics are
continued and the NMS goes unrecognised.
The pathogenesis of NMS is uncertain. It is
postulated that the neuroleptics block dopami-
nergic pathways concerned with thermoregula-
tion.? This does not explain why only a few
predisposed individuals develop the NMS. It is
most likely to be an idiosyncratic reaction as
reintroduction of the offending drug usually does
not result in recurrence of NMS. 3
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Fig. 1 Temperature chart indicating the days the patient was given medication and upon stopping.
177Management of NMS is mainly supportive."
The offending drugs should be discontinued
immediately and the patient given good nursing
care - regards tepid sponging, feeding and moni-
toring vital functions. Diazepam, anticholinergics
and dantrolene have been suggested and these
arose mainly out of single case reports. No con-
sensus has been reached as to the value of these
treatments.
This patient recovered on conservative manage-
ment and on stopping the phenothiazine. One
unusual feature is that the NMS recurred on
introducing another neuroleptic. Recent review
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of NMS suggest that reintroduction of neurolep-
tics often do not result in recurrence of NMS.
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